Abstract
THE tumour-suppressor gene p53 is inactivated in most human malignancies1 either by missense mutations1 or by binding to oncogenic proteins2–4. In human soft tissue sarcomas, inactivation apparently results from MDM2 gene amplification4. MDM2 is an oncogene product5,6 that may function by binding to p53 and inhibiting its ability to activate transcription3. Here we show that, when expressed in Saccharomyces cerevisiae, human MDM2 inhibits human p53's ability to stimulate transcription by binding to a region that nearly coincides with the p53 acidic activation domain. The isolated p53 activation domain fused to another DNA-binding protein is also inactivated by MDM2, confirming that MDM2 can inhibit p53 function by concealing the activation domain of p53 from the cellular transcription machinery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. Science 253, 49–53 (1991).
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. Cell 63, 1129–1136 (1990).
Momand, J., Zambetti, G. P., Olson, D. C. George, D. & Levine, A. J. Cell 69, 1237–1245 (1992).
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L. & Vogelstein, B. Nature 358, 80–83 (1992).
Fakharzadeh, S., Trusko, R. S. & George, D. EMBO J. 10, 1565–1569 (1991).
Finlay, C. A. Molec. cell. Biol. 13, 301–306 (1993).
Vogelstein, B. & Kinzler, K. W. Cell 70, 523–526 (1992).
Kern, S. E. et al. Science 256, 827–830 (1992).
Kamens, J., Richardson, P., Mosialos, G., Brent, R. & Gilmore, T. Molec. cell. Biol. 10, 2840–2847 (1990).
Fields, S. & Jang, S. K. Science 249, 1046–1049 (1990).
Raycroft, L., Wu, H. & Lozano, G. Science 249, 1049–1051 (1990).
Unger, T., Nau, M. M., Segal, S. & Minna, J. D. EMBO J. 11, 1383–1390 (1992).
Miller, C. W., Imai, Y., Aslo, A., Li, L. & Koefler, H. P. Proc. Am. Assoc. Cancer Res. 33, 386 (1992).
Stenger, J. E., Mayr, G. A., Mann, K. & Tegtmeyer, P. Molec. Carcinogen. 5, 102–106 (1992).
Sturzbecher, H. W. et al. Oncogene 7, 1513–1523 (1992).
Friedman, P. N., Chen, X., Bargonetti, J. & Prives, C. Proc. natn. Acad. Sci. U.S.A. (in the press).
Milner, J. & Medcalf, E. A. Cell 65, 765–774 (1991).
Leuther, K. K. & Johnston, S. A. Science 256, 1333–1335 (1992).
Ma, J. & Ptashne, M. Cell 50, 137–142 (1987).
Nigro, J. M., Sikorski, R., Reed, S. I. & Vogelstein, B. Molec. cell. Biol. 12, 1357–1365 (1992).
Ruden, D. M., Ma, J., Li, Y., Wood, K. & Ptashne, M. Nature 350, 250–252 (1991).
Poon, D. et al. Molec. cell. Biol. 11, 4809–4821 (1991).
Dalton, S., & Treisman, R. Cell 68, 597–612 (1992).
Kinzler, K. W. & Vogelstein, B. Nucleic Acids Res. 17, 3645–3653 (1989).
Golemis, E. A. & Brent, R. Molec. cell. Biol. 12, 3006–3014 (1992).
Fields, S., & Song, O. Nature 340, 245–246 (1989).
Ebina, Y. Y. et al. J. biol. Chem. 258, 13258–13261 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oliner, J., Pietenpol, J., Thiagalingam, S. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857–860 (1993). https://doi.org/10.1038/362857a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/362857a0
This article is cited by
-
Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?
Cell Death & Differentiation (2024)
-
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells
Scientific Reports (2023)
-
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Cell Death & Differentiation (2023)
-
Roles of NOLC1 in cancers and viral infection
Journal of Cancer Research and Clinical Oncology (2023)
-
Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressor
Experimental Hematology & Oncology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.